Investigating how certain brain receptors affect cognitive issues in Parkinson's disease
Official title: The role of cortical nicotinic receptors in pathological brain oscillations in Parkinson's disease cognitive impairment
Funded at Johns Hopkins University · NIH-10774326 · Data updated 2026-11-12
This study is looking at how certain brain receptors might be linked to thinking problems in people with Parkinson's disease, using special imaging and tests to better understand these connections and find new ways to help improve memory and thinking skills.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | February 15, 2023 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $204,688 |
| NIH project number | 5R21NS128391-02 |
| Project ID | NIH-10774326 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are experiencing cognitive impairment.
✕Less likely to help
Patients with Parkinson's disease who do not exhibit cognitive impairment may not benefit from this research.
What this research studies
This research explores the role of α4β2 nicotinic cholinergic receptors in the brain and their connection to cognitive impairment in Parkinson's disease (PD). By using advanced imaging techniques and cognitive testing, the study aims to understand how changes in these receptors contribute to abnormal brain oscillations that affect cognitive functions. The research combines molecular imaging with intracranial recordings to gather detailed data on brain activity and receptor signaling. This approach may help identify new treatment targets for cognitive deficits in PD.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for cognitive impairment in patients with Parkinson's disease.
How similar studies have gone: Previous research has shown promising results in understanding the role of nicotinic receptors in cognitive functions, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Mills, Kelly Alexander — Johns Hopkins University
- Study coordinator: Mills, Kelly Alexander
Related research
Other NIH-funded projects on the same topics.
-
Blood and spinal fluid markers that signal thinking problems in Parkinson's disease
This project looks for chemical fingerprints in blood and cerebrospinal fluid that might signal when people with Parkinson's disease start having memory and thinking problems.
-
Finding markers in the blood to predict cognitive decline in Parkinson's disease.
This study is looking for clues in the blood and spinal fluid of people with Parkinson's disease to help predict when they might start having trouble with thinking and memory, so that doctors can better plan treatments and trials for those affected.
-
The role of gut bacteria in cognitive issues related to Parkinson's disease
This study is looking at how the bacteria in your gut might affect thinking and memory problems in people with Parkinson's disease, hoping to find new ways to help improve these symptoms.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Global picture of dementia risk and memory loss across the world
A large international effort gathers data from many studies to understand how dementia and memory problems develop around the world, using shared information to reveal patterns and risk factors.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.